Duchenne muscular dystrophy: open trials in Spain

15 open trials have a site in Spain. Registry data; only the trial team decides who can take part.

2023-504520-26-00
Study in which all the patients take the same investigational drug with the aim of evaluate the long-term safety, tolerability, and efficacy of GIVINOSTAT in all the patients affected with Duchenne Muscolar Dystrophy who have been already treated in one of the GIVINOSTAT studies in the past
Trial Treatment · Phase 3 · Italfarmaco S.p.A.
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Sant Joan De Deu Barcelona, Esplugues de Llobregat · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-11-06
NCT07587242
A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping
Trial Treatment · Phase 3 · Avidity Biosciences, Inc.
Hospital Sant Joan de Déu, Barcelona · Hospital Universitario La Paz, Madrid · Hospital Viamed Santa Angela De la Cruz - FutureMeds Spain, Seville
Registry updated 2026-10-13
NCT07856329
A Clinical Study to Assess Safety, Efficacy and Pharmacodynamic Profile of GNT0004 in Duchenne Muscular Dystrophy
Trial Treatment · Phase 2/3 · Genethon
Hospital Sant Joan De Deu Barcelona, Esplugues de Llobregat · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-10-13
NCT07160634
A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)
Trial Treatment · Phase 3 · Solid Biosciences Inc.
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Sant Joan De Deu Barcelona, Esplugues de Llobregat · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-09-28
NCT06066580
Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy
Trial Treatment · Phase 2 · Edgewise Therapeutics, Inc.
Hospital Universitario Vall d'Hebron, Barcelona · Hospital Universitario de Bellvitge, Barcelona · Hospital Universitario Donostia, Donostia / San Sebastian · Hospital Universitari i Politécnic La Fe, Valencia
Registry updated 2026-09-17
NCT07037862
A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and Efficacy of ENTR-601-44
Trial Treatment · Phase 1/2 · Entrada Therapeutics, Inc.
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Sant Joan De Deu Barcelona, Esplugues de Llobregat
Registry updated 2026-08-13
NCT07038824
A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping to Evaluate the Safety and Efficacy of ENTR-601-45
Trial Treatment · Phase 1/2 · Entrada Therapeutics, Inc.
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Sant Joan De Deu Barcelona, Esplugues de Llobregat
Registry updated 2026-08-13
NCT05933057
Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy
Trial Treatment · Phase 3 · Italfarmaco
Hospital Sant Joan De Deu Barcelona, Esplugues de Llobregat · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-07-24
NCT07573631
An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of BMN 351 in Participants With Duchenne Muscular Dystrophy
Trial Treatment · Phase 2 · BioMarin Pharmaceutical
Hospital Viamed Santa Ángela de la Cruz, Sevilla
Registry updated 2026-07-24
NCT07682129
Long-Term Extension Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon Skipping to Evaluate the Safety and Efficacy of Endosomal Escape Vehicle Phosphorodiamidate Morpholino Oligomer Platform Products (ELEVATE-LTE)
Trial Treatment · Phase 2 · Entrada Therapeutics, Inc.
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Sant Joan De Deu Barcelona, Esplugues de Llobregat
Registry updated 2026-07-02
2025-523087-20-00
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Global Study with an Open-Label Extension to Evaluate the Efficacy and Safety of Intravenous AOC 1044 (delpacibart zotadirsen) for the Treatment of DMD with Gene Mutations Amenable to Exon 44 Skipping
Trial Treatment · Phase 3 · Avidity Biosciences Inc.
Hospital Sant Joan De Deu Barcelona, Esplugues de Llobregat · Hospital Universitario La Paz, Madrid · Futuremeds Spain S.L., Sevilla
Registry updated 2026-05-27
NCT03882827
Natural History of Duchenne Muscular Dystrophy
Research · Genethon
Hospital Sant Joan de Deu Esplugues de Llobregat, Esplugues de Llobregat · Hospital La Fe de Valencia, Valencia
Registry updated 2026-02-12
NCT05967351
A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study
Trial Treatment · Phase 3 · Sarepta Therapeutics, Inc.
Sant Joan De Deu Barcelona Hospital, Esplugues De Llobregat · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-02-06
NCT03373968
Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study
Trial Treatment · Phase 2/3 · Italfarmaco
Hospital Materno-Infantil, Barcelona · Neuromuscular Pathology Unit - Hospital Sant Joan de Déu, Esplugues de Llobregat · Hospital Universitario Virgen del Rocio, Seville · Hospital Universitari i Politècnic La Fe - Servicio Neurologia, Valencia
Registry updated 2026-01-21
NCT06363526
Effectiveness of 5-week Digital Respiratory Practice in Children With Duchenne and Becker Muscular Dystrophies.
Trial Treatment · University of Malaga
Rocío Martín-Valero, Málaga
Registry updated 2025-04-01

All Duchenne muscular dystrophy trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error